NeuroPace (NPCE) Interest Coverage Ratio Growth (3y) (2023 - 2026)
NeuroPace (NPCE) Interest Coverage Ratio Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -20.77% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 8.34% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 18.67% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 15.93% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | -50.44% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 43.57% |
| 10 | NeuroPace | 463.82 Mn | 412.12 Mn | 18.91 Mn | 3.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.32% |
| Mar 31, 2026 | 57.36% |
| Dec 31, 2025 | 38.02% |
| Sep 30, 2025 | 45.80% |
| Jun 30, 2025 | 58.28% |
| Mar 31, 2025 | 24.02% |
| Dec 31, 2024 | 44.41% |
| Sep 30, 2024 | 17.37% |
| Jun 30, 2024 | -4.82% |
| Mar 31, 2024 | -16.12% |
| Dec 31, 2023 | 250.55% |
| Sep 30, 2023 | -86.65% |
| Jun 30, 2023 | -59.92% |
| Mar 31, 2023 | -32.49% |